HASSABIS - TechNews

Demis Hassabis, CEO of Google DeepMind, predicts AI could end diseases and achieve radical abundance. He discusses the rapid advancements in AI and the quest for AGI, emphasizing the need …

Isomorphic Labs Secures $600 Million to Advance A.I. in Drug Discovery

April 1, 2025April 1, 2025 - by Nina Oliviera - Leave a Comment

Isomorphic Labs, Google’s A.I. drug division, has raised $600 million, led by Thrive Capital. This funding highlights their advancements in drug design using A.I., particularly with technologies like AlphaFold, which …

Tag: HASSABIS

Demis Hassabis: Pioneering AI Towards Radical Abundance and Disease Eradication